FIELD: medicine; pharmaceuticals.
SUBSTANCE: disclosed is the use of benzbromarone, or pharmaceutically suitable crystals, salts or clathrates thereof, or a pharmaceutical composition containing any of the above, in the preparation of medication for the treatment or prevention of vertebrae cervicales diseases or lumbar disk herniation in humans.
EFFECT: technical result consists in reducing pain and in improving the results of Bragard tests or the disappearance of Fenz and Sperlig symptoms after 8 days of continuous use of benzbromarone.
3 cl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AGENT BASED ON NSIAD, MUSCLE RELAXANT AND VITAMIN | 2017 |
|
RU2711624C2 |
| METHOD OF TREATING DORSOPATHY WITH ALLOPLANT BIOMATERIAL | 2015 |
|
RU2577508C1 |
| COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
| METHOD AND DEVICE FOR PHYSIOTHERAPEUTIC HEALTH IMPROVEMENT | 2012 |
|
RU2519975C1 |
| METHOD OF TREWATING POST-COMPRESSION DISTURBANCES OF PERIPHERAL NERVES FUNCTIONS IN CASE OF RADICULOPATHIES | 2007 |
|
RU2379018C2 |
| METHOD OF INTEGRATED NON-INVASIVE TREATMENT OF SPINAL DISEASES | 2011 |
|
RU2456034C1 |
| METHOD OF TREATING INTERVERTEBRAL DISK DEGENERATIONS, PROTRUSIONS AND HERNIATIONS | 2014 |
|
RU2556959C1 |
| METHOD FOR INTEGRATED TREATMENT OF SPINAL DISEASES | 2014 |
|
RU2572298C1 |
| METHOD OF TREATMENT OF LUMBAR INTERVERTEBRAL DISC HERNIAS | 2014 |
|
RU2577239C1 |
| METHOD FOR PREVENTION OF COMPLICATIONS ACCOMPANYING LUMBAR OSTEOCHONDROSIS | 2014 |
|
RU2570765C2 |
